Percutaneous Nerve Evaluation Trial for Overactive Bladder
This study is looking at a procedure called sacral neuromodulation (SNM) for women who have urge incontinence (leaking urine when you feel a sudden urge), urgency-frequency syndrome (frequent and sudden urges to urinate), or overactive bladder. SNM uses a small electrical stimulation to a nerve to help improve bladder control. Before getting a permanent SNM device, patients undergo a trial phase. This study is specifically looking at how many women who try a percutaneous nerve evaluation (PNE) — a temporary test with a wire and external stimulation — go on to get the full SNM implant. You may be able to join if you are a non-pregnant woman at least 18 years old with significant urge incontinence or urgency-frequency, and are already considering SNM treatment with a PNE.
- Study design
- This is an interventional study, meaning participants will receive a specific treatment. It aims to enroll 193 women.
- What's involved
- You would undergo a percutaneous nerve evaluation (PNE) as part of the sacral neuromodulation (SNM) treatment process.
- Compensation
- Not stated in the trial record.
- Follow-up
- The main goal of the study is measured at 3 or 7 days, depending on the treatment arm.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Percutaneous Nerve Evaluation Trial Time
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kimberly Kenton, MD · PRINCIPAL_INVESTIGATOR · University of Chicago
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Rate of progression onto full sacral neuomodulation (SNM) implant3 or 7 days depending on treatment arm
Participants with an adequate therapeutic response during percutaneous nerve evaluation (PNE) trial (\>/=50% improvement in urgency urinary incontinence (UUI)/ urgency-frequency (UF) symptoms) will progress onto full SNM implantation